1 / 26

IMPLEMENTATION OF BENCHMARKING GUIDELINES IN COMMUNITY PHARMACIES

IMPLEMENTATION OF BENCHMARKING GUIDELINES IN COMMUNITY PHARMACIES. WK Wong 1 , SS Chua 1 , JSH Tan 2 1 Department of Pharmacy, Faculty of Medicine, University of Malaya 2 Malaysian Pharmaceutical Society, Kuala Lumpur. CONTENTS. Introduction Aim and Objectives Methodology

agatha
Télécharger la présentation

IMPLEMENTATION OF BENCHMARKING GUIDELINES IN COMMUNITY PHARMACIES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMPLEMENTATION OF BENCHMARKING GUIDELINES IN COMMUNITY PHARMACIES WK Wong1, SS Chua1, JSH Tan2 1 Department of Pharmacy, Faculty of Medicine, University of Malaya 2 Malaysian Pharmaceutical Society, Kuala Lumpur

  2. CONTENTS • Introduction • Aim and Objectives • Methodology • Results and Discussion • Conclusions

  3. INTRODUCTION

  4. INTRODUCTION • BENCHMARKING GUIDELINES (BMGs): • Pharmaceutical Services Division of MOH has collaborated with the MPS to develop BMGs • Adopted by all registered CPs by Jan 2006. • Areas - premises, equipments, personnel, references and SOPs

  5. AIM & OBJECTIVES

  6. AIM & OBJECTIVES AIM To determine the extent community pharmacies have complied with the BMGs OBJECTIVES 1) To investigate the time frame required for community pharmacies to adopt the BMGs. 2) To identify problems associated with the implementation of BMGs

  7. METHODOLOGY

  8. METHODOLOGY 371 respondents (29.19%) Exclusion: Ceased operation Shifted Chain pharmacy with no pharmacist [ 1271 CPs] Figure 1: Flowchart of Methodology

  9. RESULTS & DISCUSSION

  10. Table 1: Demographic Data of Respondents

  11. Figure 2 : Types of Ownership of CPs (n=370) I – Independent C – Chain

  12. Figure 3: Types of services provided by CPs (n=371)

  13. Compliance to BMGs • 51.0% of the respondents were aware of the BMGs • Mean + SD extent of compliance  62.55 + 21.1, median = 65%

  14. Table 2: Percentage of compliance with premises requirement in BMGs and it’s association with types of ownership

  15. Table 3: Percentage of compliance with equipments requirement in BMGs and it’s association with types of ownership

  16. Figure 6:Percentage of Compliance with Personnel and References Requirement in BMGs

  17. Table 4: Percentage of compliance with personnel and references requirement in BMGs and it’s association with types of ownership

  18. Table 5: Percentage of compliance with Written Standard Operating Procedures (SOPs) requirement in BMGs and it’s association with types of ownership

  19. Figure 8: Reasons for not complying with BMGs(n=371)

  20. Figure 9:Comparison of Reasons between Independent Pharmacy and Chain Pharmacy for not complying with BMGs

  21. CONCLUSION

  22. CONCLUSION • Level of compliance with benchmarking guidelines varied between CPs. • Need to review the guidelines before it is implemented fully. • Professional bodies and authorities concerned should identify problems for implementation and provide more information or assistance

  23. THANK YOU

More Related